$16.5 Million Investment Helps MicroCHIPS Fund Clinical Trials for Implantable Devices

by Brendon Nafziger, DOTmed News Associate Editor | January 13, 2010

"The most important thing to demonstrate is pharmacokinetics," she says.

As with the glucose monitoring device, MicroCHIPS hopes to bring the implantable osteoporosis drug product to human trials at some point this year.

Back to HCB News

You don’t have to invest heavily in CT technology to achieve your Coronary CTA goals

Fast-moving cardiac structures have a big impact on imaging. Fujifilm’s SCENARIA View premium performance CT brings solutions to address motion in Coronary CTA while delivering unique dose saving and workflow increasing benefits.